OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Disease Statistics
Churg-Strauss disease is said to account for slightly more than 2% of all vasculitic illnesses. The various primary systemic vasculitides (Churg-Strauss disease, PAN, microscopic polyangiitis, Wegener granulomatosis) together are estimated to affect 15-25 individuals per million individuals in North America annually. Little information is available concerning international variation in the prevalence or incidence of Churg-Strauss disease.
Current Research
The ongoing research work related to Churg-Strauss syndrome include A Double-blind, Randomised, Placebo-controlled Study to Investigate the Efficacy and Safety of Mepolizumab in the Treatment of Churg-Strauss syndrome in Subjects Receiving Standard of Care Therapy, Cytokine production profile of CD4+ T cells from patients with active Churg-Strauss syndrome tends toward Th17, Longitudinal Protocol for Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) etc…